American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 01/2010, Volume 181, Issue 2, pp. 168 - 173
Rationale: The short-term prognosis of pulmonary embolism (PE) depends on hemodynamic status and underlying disease. The prognostic value of right ventricular...
Pulmonary embolism | Echocardiography | Prognosis | Natriuretic peptides | natriuretic peptides | RECLASSIFICATION | METAANALYSIS | RESPIRATORY SYSTEM | echocardiography | VALIDATION | MODEL | pulmonary embolism | prognosis | CRITICAL CARE MEDICINE | Multivariate Analysis | Recurrence | Venous Thromboembolism - mortality | Prospective Studies | Humans | Middle Aged | Shock, Cardiogenic - mortality | Male | Shock, Cardiogenic - physiopathology | Cause of Death | Troponin I - blood | Peptide Fragments - blood | Female | Natriuretic Peptide, Brain - blood | Pulmonary Embolism - genetics | Acute Disease | Hospital Mortality | Risk Assessment | Survival Rate | Models, Statistical | Venous Thromboembolism - physiopathology | Aged | Cohort Studies | Pulmonary Embolism - physiopathology | Life Sciences | Pharmacology | Pharmaceutical sciences
Pulmonary embolism | Echocardiography | Prognosis | Natriuretic peptides | natriuretic peptides | RECLASSIFICATION | METAANALYSIS | RESPIRATORY SYSTEM | echocardiography | VALIDATION | MODEL | pulmonary embolism | prognosis | CRITICAL CARE MEDICINE | Multivariate Analysis | Recurrence | Venous Thromboembolism - mortality | Prospective Studies | Humans | Middle Aged | Shock, Cardiogenic - mortality | Male | Shock, Cardiogenic - physiopathology | Cause of Death | Troponin I - blood | Peptide Fragments - blood | Female | Natriuretic Peptide, Brain - blood | Pulmonary Embolism - genetics | Acute Disease | Hospital Mortality | Risk Assessment | Survival Rate | Models, Statistical | Venous Thromboembolism - physiopathology | Aged | Cohort Studies | Pulmonary Embolism - physiopathology | Life Sciences | Pharmacology | Pharmaceutical sciences
Journal Article
Conference Proceeding
The New England Journal of Medicine, ISSN 0028-4793, 04/2014, Volume 370, Issue 15, pp. 1402 - 1411
In a randomized trial, 1006 patients with intermediate-risk pulmonary embolism were assigned to tenecteplase or placebo in addition to standard heparin...
MEDICINE, GENERAL & INTERNAL | MANAGEMENT | VENOUS THROMBOEMBOLISM | ELEVATION | COMPLICATIONS | ECHOCARDIOGRAPHY | THROMBOLYTIC THERAPY | RIGHT-VENTRICULAR ENLARGEMENT | PROGNOSTIC ROLE | Pulmonary Embolism - complications | Age Factors | Double-Blind Method | Humans | Middle Aged | Risk Factors | Heparin - therapeutic use | Male | Treatment Outcome | Tissue Plasminogen Activator - therapeutic use | Heparin - adverse effects | Tissue Plasminogen Activator - adverse effects | Pulmonary Embolism - mortality | Fibrinolytic Agents - adverse effects | Stroke - chemically induced | Fibrinolytic Agents - therapeutic use | Ventricular Dysfunction, Right - etiology | Aged, 80 and over | Troponin - blood | Female | Pulmonary Embolism - drug therapy | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Pulmonary embolism | Evaluation | Usage | Care and treatment | Fibrinolysis | Heart | Stroke | Heart attacks | Echocardiography | Embolisms | Pulmonary arteries | Hemorrhage | Bleeding | Embolism | Blood clots | Troponin T | Fibrin | Troponin | Troponin I | Motivation | Computed tomography | Ischemia | Calcium-binding protein | Heparin | Ventricle | Drug therapy | Ventricular Dysfunction, Right | Fibrinolytic Agents | Life Sciences | Tissue Plasminogen Activator | Pulmonary Embolism
MEDICINE, GENERAL & INTERNAL | MANAGEMENT | VENOUS THROMBOEMBOLISM | ELEVATION | COMPLICATIONS | ECHOCARDIOGRAPHY | THROMBOLYTIC THERAPY | RIGHT-VENTRICULAR ENLARGEMENT | PROGNOSTIC ROLE | Pulmonary Embolism - complications | Age Factors | Double-Blind Method | Humans | Middle Aged | Risk Factors | Heparin - therapeutic use | Male | Treatment Outcome | Tissue Plasminogen Activator - therapeutic use | Heparin - adverse effects | Tissue Plasminogen Activator - adverse effects | Pulmonary Embolism - mortality | Fibrinolytic Agents - adverse effects | Stroke - chemically induced | Fibrinolytic Agents - therapeutic use | Ventricular Dysfunction, Right - etiology | Aged, 80 and over | Troponin - blood | Female | Pulmonary Embolism - drug therapy | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Pulmonary embolism | Evaluation | Usage | Care and treatment | Fibrinolysis | Heart | Stroke | Heart attacks | Echocardiography | Embolisms | Pulmonary arteries | Hemorrhage | Bleeding | Embolism | Blood clots | Troponin T | Fibrin | Troponin | Troponin I | Motivation | Computed tomography | Ischemia | Calcium-binding protein | Heparin | Ventricle | Drug therapy | Ventricular Dysfunction, Right | Fibrinolytic Agents | Life Sciences | Tissue Plasminogen Activator | Pulmonary Embolism
Journal Article
Cell Reports, ISSN 2211-1247, 08/2015, Volume 12, Issue 6, pp. 1056 - 1068
Adeno-associated virus (AAV) vectors have emerged as a gene-delivery platform with demonstrated safety and efficacy in a handful of clinical trials for...
ADENOASSOCIATED VIRUS TYPE-2 | MAXIMUM-LIKELIHOOD | SEROTYPE 9 | NEUTRALIZING ANTIBODIES | CLINICAL-TRIAL | SEQUENCE ALIGNMENT | TRANSDUCTION | SELECTION | LEBERS CONGENITAL AMAUROSIS | DIRECTED EVOLUTION | CELL BIOLOGY | Molecular Sequence Data | Dependovirus - genetics | Gene Transfer Techniques | Genetic Therapy | Genetic Vectors - genetics | ancestral reconstruction | synthetic biology | vaccine | AAV | pre-existing immunity | gene therapy | neutralizing antibody | Gene Transfer | adeno-associated virus | vector | capsid T-cell | virus
ADENOASSOCIATED VIRUS TYPE-2 | MAXIMUM-LIKELIHOOD | SEROTYPE 9 | NEUTRALIZING ANTIBODIES | CLINICAL-TRIAL | SEQUENCE ALIGNMENT | TRANSDUCTION | SELECTION | LEBERS CONGENITAL AMAUROSIS | DIRECTED EVOLUTION | CELL BIOLOGY | Molecular Sequence Data | Dependovirus - genetics | Gene Transfer Techniques | Genetic Therapy | Genetic Vectors - genetics | ancestral reconstruction | synthetic biology | vaccine | AAV | pre-existing immunity | gene therapy | neutralizing antibody | Gene Transfer | adeno-associated virus | vector | capsid T-cell | virus
Journal Article
European Respiratory Journal, ISSN 0903-1936, 09/2013, Volume 42, Issue 3, pp. 681 - 688
We analysed a cohort of patients with normotensive pulmonary embolism (PE) in order to assess whether combining echocardiography and biomarkers with the...
RIGHT-VENTRICULAR DYSFUNCTION | LOW-RISK PATIENTS | PROSPECTIVE VALIDATION | METAANALYSIS | MODEL | RESPIRATORY SYSTEM | Severity of Illness Index | Multivariate Analysis | Pulmonary Embolism - complications | Recurrence | Echocardiography | Prognosis | Humans | Middle Aged | Risk Factors | Logistic Models | Male | Biomarkers - blood | Heart Ventricles - diagnostic imaging | Troponin I - blood | Pulmonary Embolism - mortality | Pulmonary Embolism - diagnosis | Shock, Cardiogenic - etiology | Female | Aged | Dilatation, Pathologic - diagnostic imaging | Natriuretic Peptide, Brain - blood | Cohort Studies
RIGHT-VENTRICULAR DYSFUNCTION | LOW-RISK PATIENTS | PROSPECTIVE VALIDATION | METAANALYSIS | MODEL | RESPIRATORY SYSTEM | Severity of Illness Index | Multivariate Analysis | Pulmonary Embolism - complications | Recurrence | Echocardiography | Prognosis | Humans | Middle Aged | Risk Factors | Logistic Models | Male | Biomarkers - blood | Heart Ventricles - diagnostic imaging | Troponin I - blood | Pulmonary Embolism - mortality | Pulmonary Embolism - diagnosis | Shock, Cardiogenic - etiology | Female | Aged | Dilatation, Pathologic - diagnostic imaging | Natriuretic Peptide, Brain - blood | Cohort Studies
Journal Article
Actes de la recherche en sciences sociales, ISSN 0335-5322, 03/2015, Issue 206-207, pp. 138 - 155
Passed in 2009, the HADOPI law has created a system of sanctions directed against the illegal downloading of cultural goods. Directors belonging to several...
Journal Article
ACTES DE LA RECHERCHE EN SCIENCES SOCIALES, ISSN 0335-5322, 03/2015, Issue 206, pp. 138 - 155
Journal Article
Actes de la recherche en sciences sociales, ISSN 0335-5322, 2015, Volume 206-207, Issue 1, pp. 138 - 155
Adoptée en 2009, la loi HADOPI a mis en place un dispositif de sanction des pratiques de téléchargement illégal de biens culturels. À travers des pétitions,...
Journal Article
Actes de la Recherche en Sciences Sociales, ISSN 0335-5322, 2015, Issue 206-207, pp. 138 - 155
Journal Article
Actes de la recherche en sciences sociales, ISSN 0335-5322, 2015, Volume 206-207, Issue 1, p. 138
Journal Article
Chest, ISSN 0012-3692, 2008, Volume 133, Issue 2, pp. 358 - 362
Background: In the literature, echocardiographic assessment of the prognosis of acute pulmonary embolism is based on analysis of right ventricle free-wall...
Pulmonary embolism | Logistic regression | Hospital mortality | Echocardiography | Prognosis | Right ventricular dysfunction | DIAGNOSIS | MANAGEMENT | PREDICTOR | echocardiography | CHEST COMPUTED-TOMOGRAPHY | ENLARGEMENT | prognosis | DOPPLER | PRESSURE | RESPIRATORY SYSTEM | CARDIAC TROPONIN-T | right ventricular dysfunction | DYSFUNCTION | logistic regression | pulmonary embolism | hospital mortality | CRITICAL CARE MEDICINE | Ventricular Dysfunction, Left | Hospital Mortality | Ventricular Dysfunction, Right | Humans | Middle Aged | Logistic Models | Male | Heart Ventricles - diagnostic imaging | Pulmonary Embolism - mortality | Ultrasonography | Female | Registries | Aged | Retrospective Studies | Pulmonary Embolism - diagnostic imaging | Pulmonary Embolism - physiopathology
Pulmonary embolism | Logistic regression | Hospital mortality | Echocardiography | Prognosis | Right ventricular dysfunction | DIAGNOSIS | MANAGEMENT | PREDICTOR | echocardiography | CHEST COMPUTED-TOMOGRAPHY | ENLARGEMENT | prognosis | DOPPLER | PRESSURE | RESPIRATORY SYSTEM | CARDIAC TROPONIN-T | right ventricular dysfunction | DYSFUNCTION | logistic regression | pulmonary embolism | hospital mortality | CRITICAL CARE MEDICINE | Ventricular Dysfunction, Left | Hospital Mortality | Ventricular Dysfunction, Right | Humans | Middle Aged | Logistic Models | Male | Heart Ventricles - diagnostic imaging | Pulmonary Embolism - mortality | Ultrasonography | Female | Registries | Aged | Retrospective Studies | Pulmonary Embolism - diagnostic imaging | Pulmonary Embolism - physiopathology
Journal Article
Human Gene Therapy, ISSN 1043-0342, 07/2018, Volume 29, Issue 7, pp. 771 - 784
Gene therapy is a promising approach in the treatment of inherited and common complex disorders of the retina. Preclinical and clinical studies have validated...
Research Articles | gene therapy | in silico reconstruction | adeno-associated virus | cone photoreceptors | retina | retinal transduction | Retina - drug effects | Dependovirus - genetics | Gene Transfer Techniques | Genetic Therapy | Retinal Diseases - genetics | Retinal Pigment Epithelium - metabolism | Retina - metabolism | Transduction, Genetic | Genetic Vectors - administration & dosage | Humans | Retinal Diseases - therapy | Macaca mulatta | Retinal Rod Photoreceptor Cells - metabolism | Genetic Vectors - genetics | Retinal Pigment Epithelium - pathology | Animals | Retinal Cone Photoreceptor Cells - pathology | Retinal Diseases - pathology | Mice | Retina - pathology | Retinal Cone Photoreceptor Cells - metabolism | Retinal Rod Photoreceptor Cells - pathology | OCULAR SUBRETINAL INJECTION | MEDICINE, RESEARCH & EXPERIMENTAL | VIRUS | FOLLOW-UP | LONG-TERM PRESERVATION | MODEL | BIPOLAR CELLS | LEBER CONGENITAL AMAUROSIS | GENE AUGMENTATION THERAPY | AAV VECTOR | VISUAL FUNCTION | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENETICS & HEREDITY | Tropism | Gene transfer | Retinal cells | Retina | Rods | mRNA | Gene expression | Epithelium | Neuronal-glial interactions | Retinal pigment epithelium | Retinal ganglion cells | Primates | Photoreceptors | Kinetics | Gene therapy | Expression vectors
Research Articles | gene therapy | in silico reconstruction | adeno-associated virus | cone photoreceptors | retina | retinal transduction | Retina - drug effects | Dependovirus - genetics | Gene Transfer Techniques | Genetic Therapy | Retinal Diseases - genetics | Retinal Pigment Epithelium - metabolism | Retina - metabolism | Transduction, Genetic | Genetic Vectors - administration & dosage | Humans | Retinal Diseases - therapy | Macaca mulatta | Retinal Rod Photoreceptor Cells - metabolism | Genetic Vectors - genetics | Retinal Pigment Epithelium - pathology | Animals | Retinal Cone Photoreceptor Cells - pathology | Retinal Diseases - pathology | Mice | Retina - pathology | Retinal Cone Photoreceptor Cells - metabolism | Retinal Rod Photoreceptor Cells - pathology | OCULAR SUBRETINAL INJECTION | MEDICINE, RESEARCH & EXPERIMENTAL | VIRUS | FOLLOW-UP | LONG-TERM PRESERVATION | MODEL | BIPOLAR CELLS | LEBER CONGENITAL AMAUROSIS | GENE AUGMENTATION THERAPY | AAV VECTOR | VISUAL FUNCTION | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENETICS & HEREDITY | Tropism | Gene transfer | Retinal cells | Retina | Rods | mRNA | Gene expression | Epithelium | Neuronal-glial interactions | Retinal pigment epithelium | Retinal ganglion cells | Primates | Photoreceptors | Kinetics | Gene therapy | Expression vectors
Journal Article
Molecular Therapy, ISSN 1525-0016, 06/2017, Volume 25, Issue 6, pp. 1375 - 1386
Adeno-associated virus (AAV) vectors are promising clinical candidates for therapeutic gene transfer, and a number of AAV-based drugs may emerge on the market...
capsid thermostability | quality control | identity | CMC | manufacturing | gene therapy | AAV vectors | adeno-associated virus | identity assay | homogeneity | MEDICINE, RESEARCH & EXPERIMENTAL | HEPARIN-BINDING | RECOMBINANT ADENOASSOCIATED VIRUS | REFERENCE-STANDARD MATERIAL | RECONSTRUCTION | LIPASE-DEFICIENT PATIENTS | GENE-THERAPY VECTOR | VIRAL VECTORS | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | CAPSID STABILITY | GENETICS & HEREDITY | DIFFERENTIAL SCANNING FLUOROMETRY | PROTEINS | Reproducibility of Results | Capsid - chemistry | Dependovirus - isolation & purification | Humans | Spectrometry, Fluorescence | Structure-Activity Relationship | Genetic Vectors - standards | Dependovirus - physiology | Genetic Vectors - isolation & purification | Thermodynamics | Capsid Proteins - chemistry | Mutation | Protein Stability | Capsid Proteins - genetics | Solvents | Gene transfer | Laboratories | Genomes | Drug development | Thermal stability | Proteins | Serotypes | Software | Manufacturing | Gene therapy | Deoxyribonucleic acid--DNA | Biotechnology industry | Expression vectors | Life Sciences | Original
capsid thermostability | quality control | identity | CMC | manufacturing | gene therapy | AAV vectors | adeno-associated virus | identity assay | homogeneity | MEDICINE, RESEARCH & EXPERIMENTAL | HEPARIN-BINDING | RECOMBINANT ADENOASSOCIATED VIRUS | REFERENCE-STANDARD MATERIAL | RECONSTRUCTION | LIPASE-DEFICIENT PATIENTS | GENE-THERAPY VECTOR | VIRAL VECTORS | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | CAPSID STABILITY | GENETICS & HEREDITY | DIFFERENTIAL SCANNING FLUOROMETRY | PROTEINS | Reproducibility of Results | Capsid - chemistry | Dependovirus - isolation & purification | Humans | Spectrometry, Fluorescence | Structure-Activity Relationship | Genetic Vectors - standards | Dependovirus - physiology | Genetic Vectors - isolation & purification | Thermodynamics | Capsid Proteins - chemistry | Mutation | Protein Stability | Capsid Proteins - genetics | Solvents | Gene transfer | Laboratories | Genomes | Drug development | Thermal stability | Proteins | Serotypes | Software | Manufacturing | Gene therapy | Deoxyribonucleic acid--DNA | Biotechnology industry | Expression vectors | Life Sciences | Original
Journal Article
Chest, ISSN 0012-3692, 2001, Volume 120, Issue 1, pp. 120 - 125
Study objectives: To assess the potential benefit of thrombolysis in patients with massive pulmonary embolism (PE) with stable hemodynamics and right...
Massive pulmonary embolism | Heparin | Low-molecular-weight heparin | Thrombolysis | Right ventricular dysfunction | CARDIAC & CARDIOVASCULAR SYSTEMS | massive pulmonary embolism | MYOCARDIAL-INFARCTION | ECHOCARDIOGRAPHIC EVALUATION | MULTICENTER REGISTRY | DOPPLER | INTRACRANIAL HEMORRHAGE | RANDOMIZED TRIAL | heparin | PLASMINOGEN-ACTIVATOR | SARUPLASE | RESPIRATORY SYSTEM | thrombolysis | MOLECULAR-WEIGHT HEPARINS | low-molecular-weight heparin | right ventricular dysfunction | UNFRACTIONATED HEPARIN | Recurrence | Humans | Heparin - therapeutic use | Male | Lung - diagnostic imaging | Pulmonary Artery - diagnostic imaging | Heparin - adverse effects | Fibrinolytic Agents - adverse effects | Dilatation | Fibrinolytic Agents - therapeutic use | Aged, 80 and over | Ventilation-Perfusion Ratio | Female | Retrospective Studies | Heart Ventricles - pathology | Pulmonary Embolism - complications | Echocardiography | Radiography | Pulmonary Embolism - diagnosis | Radionuclide Imaging | Ventricular Dysfunction, Right - complications | Plasminogen Activators - therapeutic use | Pulmonary Embolism - drug therapy | Aged | Hemorrhage - chemically induced | Thrombolytic Therapy - adverse effects | Ventricular Dysfunction, Right - pathology | Cohort Studies | Plasminogen Activators - adverse effects | Pulmonary Embolism - physiopathology | Ventricular Dysfunction, Right - diagnostic imaging | Pulmonary embolism | Evaluation | Care and treatment | Thrombolytic therapy
Massive pulmonary embolism | Heparin | Low-molecular-weight heparin | Thrombolysis | Right ventricular dysfunction | CARDIAC & CARDIOVASCULAR SYSTEMS | massive pulmonary embolism | MYOCARDIAL-INFARCTION | ECHOCARDIOGRAPHIC EVALUATION | MULTICENTER REGISTRY | DOPPLER | INTRACRANIAL HEMORRHAGE | RANDOMIZED TRIAL | heparin | PLASMINOGEN-ACTIVATOR | SARUPLASE | RESPIRATORY SYSTEM | thrombolysis | MOLECULAR-WEIGHT HEPARINS | low-molecular-weight heparin | right ventricular dysfunction | UNFRACTIONATED HEPARIN | Recurrence | Humans | Heparin - therapeutic use | Male | Lung - diagnostic imaging | Pulmonary Artery - diagnostic imaging | Heparin - adverse effects | Fibrinolytic Agents - adverse effects | Dilatation | Fibrinolytic Agents - therapeutic use | Aged, 80 and over | Ventilation-Perfusion Ratio | Female | Retrospective Studies | Heart Ventricles - pathology | Pulmonary Embolism - complications | Echocardiography | Radiography | Pulmonary Embolism - diagnosis | Radionuclide Imaging | Ventricular Dysfunction, Right - complications | Plasminogen Activators - therapeutic use | Pulmonary Embolism - drug therapy | Aged | Hemorrhage - chemically induced | Thrombolytic Therapy - adverse effects | Ventricular Dysfunction, Right - pathology | Cohort Studies | Plasminogen Activators - adverse effects | Pulmonary Embolism - physiopathology | Ventricular Dysfunction, Right - diagnostic imaging | Pulmonary embolism | Evaluation | Care and treatment | Thrombolytic therapy
Journal Article
Blood, ISSN 0006-4971, 02/2013, Volume 121, Issue 8, pp. 1326 - 1334
Despite intense scrutiny of the molecular interactions between natural killer (NK) and target cells, few studies have been devoted to dissection of the basic...
DYNAMICS | COMPLEMENT | HEMATOLOGY | DISTINCT | T-LYMPHOCYTE | T-Lymphocytes, Cytotoxic - immunology | Cell Communication - immunology | Humans | Immunophenotyping | Cell Degranulation - immunology | Time-Lapse Imaging | Killer Cells, Natural - classification | Necrosis - immunology | Cell Movement - immunology | Microchip Analytical Procedures | Killer Cells, Natural - cytology | Lymphocyte Activation - immunology | Apoptosis - immunology | Models, Biological | HEK293 Cells | Killer Cells, Natural - immunology | T-Lymphocytes, Cytotoxic - classification | T-Lymphocytes, Cytotoxic - cytology | Medical and Health Sciences | Hematology | Cell Degranulation | T-Lymphocytes | Medicin och hälsovetenskap | Lymphocyte Activation | Cell Communication | Biological | Klinisk medicin | Natural | Cytotoxic | Necrosis | Clinical Medicine | Hematologi | Killer Cells | Models | Apoptosis | Cell Movement
DYNAMICS | COMPLEMENT | HEMATOLOGY | DISTINCT | T-LYMPHOCYTE | T-Lymphocytes, Cytotoxic - immunology | Cell Communication - immunology | Humans | Immunophenotyping | Cell Degranulation - immunology | Time-Lapse Imaging | Killer Cells, Natural - classification | Necrosis - immunology | Cell Movement - immunology | Microchip Analytical Procedures | Killer Cells, Natural - cytology | Lymphocyte Activation - immunology | Apoptosis - immunology | Models, Biological | HEK293 Cells | Killer Cells, Natural - immunology | T-Lymphocytes, Cytotoxic - classification | T-Lymphocytes, Cytotoxic - cytology | Medical and Health Sciences | Hematology | Cell Degranulation | T-Lymphocytes | Medicin och hälsovetenskap | Lymphocyte Activation | Cell Communication | Biological | Klinisk medicin | Natural | Cytotoxic | Necrosis | Clinical Medicine | Hematologi | Killer Cells | Models | Apoptosis | Cell Movement
Journal Article
Cell Reports, ISSN 2211-1247, 05/2018, Volume 23, Issue 6, pp. 1817 - 1830
The adeno-associated virus (AAV) vector is a preferred delivery platform for in vivo gene therapy. Natural and engineered variations of the AAV capsid affect a...
AAP | AAV | capsid | capsid assembly | manufacturing | structure-function | gene therapy | adeno-associated virus | vector engineering | ADENOASSOCIATED VIRUS TYPE-2 | TRANSDUCTION EFFICIENCY | MOTIFS | SEROTYPE 9 | IN-VITRO | INFECTIVITY | IMPROVES | IDENTIFICATION | GENE-THERAPY VECTOR | INTRACELLULAR TRAFFICKING | CELL BIOLOGY
AAP | AAV | capsid | capsid assembly | manufacturing | structure-function | gene therapy | adeno-associated virus | vector engineering | ADENOASSOCIATED VIRUS TYPE-2 | TRANSDUCTION EFFICIENCY | MOTIFS | SEROTYPE 9 | IN-VITRO | INFECTIVITY | IMPROVES | IDENTIFICATION | GENE-THERAPY VECTOR | INTRACELLULAR TRAFFICKING | CELL BIOLOGY
Journal Article
Actes de la Recherche en Sciences Sociales, ISSN 0335-5322, 2015, Volume 206-207, Issue 1
Journal Article
Cell Reports, ISSN 2211-1247, 05/2018, Volume 23, Issue 6, pp. 1817 - 1830
The adeno-associated virus (AAV) vector is a preferred delivery platform for gene therapy. Natural and engineered variations of the AAV capsid affect a...
AAP | AAV | capsid assembly | capsid | manufacturing | structure-function | gene therapy | adeno-associated virus | vector engineering | Life Sciences | Human health and pathology
AAP | AAV | capsid assembly | capsid | manufacturing | structure-function | gene therapy | adeno-associated virus | vector engineering | Life Sciences | Human health and pathology
Journal Article
Actes de la Recherche en Sciences Sociales, ISSN 0335-5322, 2015, Issue 206-207, pp. 4 - 13
Journal Article
Actes de la recherche en sciences sociales, ISSN 0335-5322, 2015, Volume 206-207, Issue 1, pp. 4 - 13
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.